Startup based in the United States, most recent round Pre-ipo.
Based in the United States, Vaxcyte is a startup. Its most recent tracked round is Pre-ipo.
Vaxcyte is a clinical-stage biotechnology company developing vaccines to prevent serious bacterial infections including invasive pneumococcal disease, Group A Streptococcus, and Shigella using advanced synthetic and cell-free protein synthesis technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.